HIT Consultant April 2, 2024
Fred Pennic

What You Should Know:

Eko Health, a provider of AI-powered heart and lung disease detection today announced FDA clearance for its Low EF detection AI.

– Built in collaboration with Mayo Clinic, the AI allows U.S. healthcare providers to detect Low Ejection Fraction (LVEF), a crucial indicator of heart failure, in just 15 seconds using a standard Eko stethoscope during a routine physical exam.

Importance of Early Detection

The advancement in early detection signifies a major medical innovation for cardiovascular disease. In the US alone, over 6 million individuals struggle with heart failure, with half experiencing HFrEF, a condition where the heart cannot pump blood efficiently. Traditionally, diagnosing heart failure often relies on echocardiography, a tool unavailable in many...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Patient / Consumer, Physician, Provider, Technology
OpenAI’s new GPT-4o lets people interact using voice or video in the same model
The Download: the future of chips, and investing in US AI
5 Common Mistakes That Risk Your Pharma AI Efforts
What’s next in chips
AI Explained: Deep Learning Lets AI Tackle Complex Tasks

Share This Article